Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11706867 | 0.92 | HSD17B10 (0.49) | HSP90AA1HSD17B10USP2HPGDCA2 | |
| SCHEMBL11707925 | 0.88 | HSP90AA1 (0.52) | HSP90AA1HSD17B10USP2HPGDCA2 | |
| SCHEMBL3174757 | 0.81 | HSP90AA1 (0.57) | HSP90AA1HSD17B10USP2HPGDCA2 | |
| SCHEMBL7593278 | 0.78 | PRSS1 (0.54) | HSP90AA1HSD17B10USP2HPGDCA2 | |
| SCHEMBL14951927 | 0.78 | HSP90AA1 (0.53) | HSP90AA1HSD17B10USP2HPGDCA2 | |
| SCHEMBL11150349 | 0.77 | HSP90AA1 (0.49) | HSP90AA1HSD17B10USP2HPGDCA2 | |
| SCHEMBL11707924 | 0.77 | CNR2 (0.50) | HSP90AA1HSD17B10USP2HPGDCA2 | |
| SCHEMBL4569291 | 0.76 | HSP90AA1 (0.52) | HSP90AA1HSD17B10USP2HPGDCA2 | |
| SCHEMBL8294096 | 0.76 | CNR2 (0.53) | HSP90AA1HSD17B10USP2HPGDCA2 | |
| SCHEMBL3822620 | 0.76 | HSP90AA1 (0.61) | HSP90AA1HSD17B10USP2HPGDCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022244-A1 | STYRENE-BUTADIENE LATEXES FOR ASPHALT EMULSION APPLICATIONS | BASF SE (DE) | 2026-01-22 | — | — | US | disclosed |
| EP-4665798-A1 | LATEXES WITH CATIONIC EMULSIFIERS FOR ASPHALT EMULSION APPLICATIONS | BASF SE (DE) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024173682-A1 | LATEXES WITH CATIONIC EMULSIFIERS FOR ASPHALT EMULSION APPLICATIONS | BASF SE (DE) | 2024-08-22 | — | — | WO | disclosed |
| WO-2023249812-A1 | STYRENE-BUTADIENE LATEXES FOR ASPHALT EMULSION APPLICATIONS | BASF SE (DE) | 2023-12-28 | — | — | WO | disclosed |
| EP-2627681-B1 | POLYMER-MODIFIED ASPHALT COMPOSITIONS | BASF SE (DE) | 2018-09-19 | — | — | EP | disclosed |
| EP-2627704-B1 | Polymer modified asphalt | BASF SE (DE) | 2018-08-22 | — | — | EP | disclosed |
| US-9815984-B2 | Non-carboxylated styrene-butadiene copolymers, preparation method and use thereof | BASF SE (DE) | 2017-11-14 | — | — | US | disclosed |
| US-20160289451-A1 | NON-CARBOXYLATED STYRENE-BUTADIENE COPOLYMERS, PREPARATION METHOD AND USE THEREOF | BASF SE (DE) | 2016-10-06 | — | — | US | disclosed |
| US-9365707-B2 | Non-carboxylated styrene-butadiene copolymers, preparation method and use thereof | BASF SE (DE) | 2016-06-14 | — | — | US | disclosed |
| US-9139720-B2 | Styrene-based copolymers having acid monomer units and dispersions thereof | BASF SE (DE) | 2015-09-22 | — | — | US | disclosed |
| US-20130289172-A1 | NON-CARBOXYLATED STYRENE-BUTADIENE COPOLYMERS, PREPARATION METHOD AND USE THEREOF | BASF SE (DE) | 2013-10-31 | — | — | US | disclosed |
| EP-2627681-A1 | STYRENE-BASED COPOLYMERS HAVING ACID MONOMER UNITS, DISPERSIONS, PREPARATION AND USE THEREOF | BASF SE (DE) | 2013-08-21 | — | — | EP | disclosed |
| WO-2012049651-A1 | STYRENE-BASED COPOLYMERS HAVING ACID MONOMER UNITS, DISPERSIONS, PREPARATION AND USE THEREOF | BASF SE (DE) | 2012-04-19 | — | — | WO | disclosed |
| US-6737469-B2 | Method of adding water insoluble organic chemicals to styrene-butadiene rubber latex dispersions and resulting styrene-butadiene rubber latex dispersions | BASF AG (DE) | 2004-05-18 | — | — | US | disclosed |
| WO-2003027171-A1 | METHOD OF ADDING INSOLUBLE ORGANIC CHEMICALS TO STYRENE-BUTADIENE RUBBER LATEX | BASF CORPORATION (US) | 2003-04-03 | — | — | WO | disclosed |
| US-20030060549-A1 | Method of adding water insoluble organic chemicals to styrene-butadiene rubber latex dispersions and resulting styrene-butadiene rubber latex dispersions | BASF CORPORATION | 2003-03-27 | — | — | US | disclosed |
| US-4053458-A | INHIBITORS | UOP INC. (US) | 1977-10-11 | — | — | US | disclosed |
| US-4022828-A | BIS-(SULFONAMIDO)-SULFIDES | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
| US-4022828-A | BIS-(SULFONAMIDO)-SULFIDES | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
| US-3919309-A | Acyl substituted phenyl alkanoic acids | SANDOZ AG | 1975-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022244-A1 | STYRENE-BUTADIENE LATEXES FOR ASPHALT EMULSION APPLICATIONS | NOTUM, PLTP, CETP | HSP90AA1 3685/4885HSD17B10 2335/4885USP2 2073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.